Palisade Bio Inc. is a clinical-stage biopharmaceutical company based in Carlsbad, California, focused on developing innovative therapies aimed at protecting the gastrointestinal mucosal barrier. The company is committed to addressing significant unmet medical needs in gastrointestinal disorders through its proprietary drug candidates, emphasizing extensive research and development efforts. With a strong pipeline and strategic initiatives, Palisade Bio is well-positioned to drive advancements in gastrointestinal health and improve patient outcomes in this critical therapeutic area.
Pre-Market Stock Futures: The futures are trading lower as we begin the final trading week of 2025, albeit a holiday-shortened one once again. The major indices all finished the session modestly lower…
